Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro.

Jorquera PA, Mathew C, Pickens J, Williams C, Luczo JM, Tamir S, Ghildyal R, Tripp RA.

J Virol. 2019 Feb 5;93(4). pii: e01684-18. doi: 10.1128/JVI.01684-18. Print 2019 Feb 15.

2.

Evolution of high pathogenicity of H5 avian influenza virus: haemagglutinin cleavage site selection of reverse-genetics mutants during passage in chickens.

Luczo JM, Tachedjian M, Harper JA, Payne JS, Butler JM, Sapats SI, Lowther SL, Michalski WP, Stambas J, Bingham J.

Sci Rep. 2018 Aug 1;8(1):11518. doi: 10.1038/s41598-018-29944-z.

3.

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.

Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, Ganti K, Cox RM, Sticher ZM, Edpuganti V, Mitchell DG, Lockwood MA, Kolykhalov AA, Greninger AL, Moore ML, Painter GR, Lowen AC, Tompkins SM, Fearns R, Natchus MG, Plemper RK.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00766-18. doi: 10.1128/AAC.00766-18. Print 2018 Aug.

4.

Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif.

Luczo JM, Stambas J, Durr PA, Michalski WP, Bingham J.

Rev Med Virol. 2015 Nov;25(6):406-30. doi: 10.1002/rmv.1846. Epub 2015 Oct 15. Review.

Supplemental Content

Loading ...
Support Center